Abstract . Low density lipoprotein (LDL) and (3-very low density lipoprotein (/3VLDL) are internalized by the same receptor in mouse peritoneal macrophages and yet their endocytic patterns differ ; (3VLDL is targeted to both widely distributed and perinuclear vesicles, whereas LDL is targeted almost entirely to perinuclear lysosomes. This endocytic divergence may have important metabolic consequences since OVLDL is catabolized slower than LDL and is a more potent stimulator of aryl-CoA/cholesterol acyl transferase (ACAT) than LDL. The goal of this study was to explore the determinants of (3VLDL responsible for its pattern of endocytic targeting. Fluorescence microscopy experiments revealed that large, intestinally derived, apoprotein (Apo) E-rich /3VLDL was targeted mostly to widely distributed vesicles, whereas small, hepatically derived OVLDL was targeted more centrally (like LDL). Furthermore, the large /3VLDL had a higher ACATstimulatory potential than the smaller OVLDL. The basis for these differences was not due to fundamental differences in the means of uptake; L NDs and receptors internalized by receptor-mediated endocytosis may undergo a variety of cellular itineraries, including targeting of both ligand and receptor to lysosomes, recycling ofboth ligand and receptor to the cell surface, or targeting of the ligand to lysosomes and receptor to the cell surface after ligand-receptor uncoupling in sorting endosomes (13). A major goal in this area of research has been to elucidate ligand-receptor properties that may influence the endocytic itinerary and thus the intracellular metabolism of individual ligands and their receptors. Along these lines, several groups have reported thatthe crosslinking of specific receptors by polyvalent antibody or multivalent ligands on gold particles can alter the endocytic itinerary of these ligands and their receptors (1, 14, 26, 29, 32, 38 both large and small RVLDL were internalized by receptor-mediated endocytosis (i.e., not phagocytosis) involving the interaction of Apo E of the ,8VLDL with the macrophage LDL receptor . However, large aVLDL was much more resistant to acid-mediated release from LDL receptors than small /3VLDL. Furthermore, partial neutralization of the multiple Apo Es on these particles by immunotitration resulted in a more perinuclear endocytic pattern, a lower ACAT stimulatory potential, and an increased sensitivity to acid-mediated receptor release. These data are consistent with the hypothesis that the interaction of the multivalent Apo Es of large (3VLDL with multiple macrophage LDL receptors leads to a diminished or retarded release of the OVLDL from its receptor in the acidic sorting endosome which, in turn, may lead to the widely distributed endocytic pattern of large aVLDL.
L
NDs and receptors internalized by receptor-mediated endocytosis may undergo a variety of cellular itineraries, including targeting of both ligand and receptor to lysosomes, recycling ofboth ligand and receptor to the cell surface, or targeting of the ligand to lysosomes and receptor to the cell surface after ligand-receptor uncoupling in sorting endosomes (13) . A major goal in this area of research has been to elucidate ligand-receptor properties that may influence the endocytic itinerary and thus the intracellular metabolism of individual ligands and their receptors. Along these lines, several groups have reported thatthe crosslinking of specific receptors by polyvalent antibody or multivalent ligands on gold particles can alter the endocytic itinerary of these ligands and their receptors (1, 14, 26, 29, 32, 38) . both large and small RVLDL were internalized by receptor-mediated endocytosis (i.e., not phagocytosis) involving the interaction of Apo E of the ,8VLDL with the macrophage LDL receptor . However, large aVLDL was much more resistant to acid-mediated release from LDL receptors than small /3VLDL. Furthermore, partial neutralization of the multiple Apo Es on these particles by immunotitration resulted in a more perinuclear endocytic pattern, a lower ACAT stimulatory potential, and an increased sensitivity to acid-mediated receptor release. These data are consistent with the hypothesis that the interaction of the multivalent Apo Es of large (3VLDL with multiple macrophage LDL receptors leads to a diminished or retarded release of the OVLDL from its receptor in the acidic sorting endosome which, in turn, may lead to the widely distributed endocytic pattern of large aVLDL.
These findings may represent a physiologically relevant example of a previously described laboratory phenomenon whereby receptor cross-linking by multivalent ligands leads to a change in receptor targeting.
Research from our laboratories has revealed that two different lipoprotein ligands for the same receptor, the macrophage low density lipoprotein (LDL) receptor, have divergent endocytic pathways in mouse peritoneal macrophages: LDL is rapidly targeted to perinuclear lysosomes near the center of the cell, whereas a significant portion of the R-very low density lipoprotein ((3VLDL) is found in more widely distributed vesicles whose interiors are relatively electron lucent when viewed by EM (37) . This finding has two potential areas of importance. Firstly, an understanding of the mechanism ofthe endocytic divergence of these two ligands may help elucidate ligand properties that are important in determining endocytic itineraries . Secondly, the divergent endocytic targeting of LDL and #VLDL in macrophages may have important physiological consequences related to their intracellular metabolism . In particular, O-VLDL is degraded more slowly and stimulates the intracellular cholesterol esterification enzyme acyl-CoA/cholesterol acyl transferase (ACAT) more potently than LDL in these cells (37) . Since macrophages which have accumulated large amounts of ACAT-derived cholesteryl ester (CE) ("foam cells") are a prominent feature of atherosclerotic lesions (8, 10, 34) and since OVLDL is known to be an "atherogenic" lipoprotein (25) , our studies on the endocytosis of /3VLDL in macrophages may contribute to our understanding ofmechanisms of atheroma foam cell formation .
The goal ofthe current study was to explore the properties of RVLDL particles that are responsible for their distinct endocytic pathway (and metabolism) in macrophages . The data revealed that not all /3VLDL particles behaved similarly : large apoprotein (Apo) E-rich, intestinally derived fl-VLDL were targeted mostly to widely distributed vesicles, whereas small, hepatically derived SVLDL were targeted more centrally (like LDL). These endocytic differences were associated with an important metabolic difference as well:
large aVLDL stimulated ACAT greater than small /3VLDL.
Several possible explanations for these endocytic (and ACAT) differences were explored, and the data suggest that binding of large ,QVLDL via multiple Apo E subunits to macrophage LDL receptors, which probably leads to receptor cross-linking, results in an alteration of the pattern of endocytosis and perhaps ACAT stimulation. Thus, these findings may represent a physiologically important example of the effects of ligand multivalency and receptor cross-linking on ligand-receptor endocytic routing.
Materials and Methods

Cells
Peritoneal macrophages from unstimulated female ICR mice (25-35g . , Harlan Sprague Dawley, Inc ., Indianapolis, IN) were plated onto coverslipbottom dishes and preincubated for 2 d in DME/10% lipoprotein-deficient serum (vol/vol) as previously described (37) . In certain experiments, the LDL receptor on the cells was partially down-regulated by adding to the preincubation medium 5 pg/ml acetyl-LDL (11) plus 1 pg/ml of the ACAT inhibitor, compound 58-035
propanamide) (31) (generously provided by Dr. John Heider, Sandoz, Inc., East Hanover, NJ) . All experiments were performed on day 3.
Lipoproteins and Proteins
LDL was prepared as previously described (37) . d < 1 .006 lipoproteins from cholesterol-fed rabbits and cholesterol-fed dogs were prepared by ultracentrifugation at d = 1 .006 g/ml (17) . These d < 1.006 lipoproteins, which contain mostly S-VLDL but also some pre-fl VLDL, will be referred to as simply "O-VLDL :' Aggregated LDL was prepared by vigorously vortexing LDL for 30 s as described by Khoo et al . (18) . The lipoproteins were labeled with 1,1'-dioctaolecyl-3,3,3 ;3'-tetramethylindocarbocyanine Perchlorate (DiI) (Molecular Probes Inc ., Junction City, OR) by the method of Pitas et al . (30) and with 125 1 (IMS .30 ; carrier-free ; Amersham Corp., Arlington Heights, IL) using iodine monochloride as described in detail previously (12) . The lipoproteins were labeled with 3H-labeled CE by transfer (via semipurified CE transfer protein) of 3 H-CE from 3 H-CE-HDL donor (36) .
The Journal of Cell Biology, Volume 115, 1991 Canine ,BVLDL lipids and proteins were analyzed for lipid composition (cholesterol, triglycerides, and phospholipid) by analysis on a Spectrum high performance diagnostic system (Abbott Laboratories, Diagnostic Div. Department, Abbott Park, IL) and for protein content by the method of Lowry et al . (24) . Negative-stain EM of the ,B VLDL was carried out as described by Boyles et al . (4) . Canine SVLDL was fractionated by gel filtration chromatography on BioGel A-150m agarose beads (Bio-Rad Laboratories, Richmond, CA) in saline-EDTA (0.15 M NaCl, 0.01% EDTA) (9) . Each fraction was analyzed by absorbance at 280 not and by colorometric cholesterol assay (Boehringer Mannheim Diagnostics, Inc., Houston, TX) to determine peaks . a2-Macroglobulin (a2M) was purified, converted to the receptorbinding form, and conjugated to FITC as previously described (33) .
Antibodies
Pblyclonal rabbit anti-bovine adrenal LDL receptor antibody was prepared as described by Schneider et al . (35) and Beisiegel et al . (3) . Monoclonal antibodies against Apo B100 (4G3, IgG2.) and Apo E (1D7, IgGi) were kindly provided by Drs . Ross Milne and Yves Marcel (Clinical Institute of Montreal, Montreal, Canada) and were characterized previously (27, 28) . The polyclonal and monoclonal antibodies were purified by protein A-Sepharose chromatography. As a control (i .e ., irrelevant) antibody, we used rabbit IgG against dinitrophenyl-BSA or mouse monoclonal IgG, against clathrin heavy chain . Anti-Apo E (1I77) Fab fragments were made by digesting the intact IgG with immobilized papain and then separating the Fab fragments from Fc fragments and undigested IgG using an immobilized protein A column (ImmunoPure Fab preparation kit, Pierce Chemical Co., Rockford, IL) .
Video Intensification Fluorescence Microscopy
Cells were incubated, washed, formaldehyde fixed, and viewed by fluorescence microscopy as described previously (37) and as indicated in the individual figure legends. Images were digitized (Gould-Vicom IP 9000 image processor, Vicom, Inc., Fremont, CA) and photographs were produced (Polaroid Freeze Frame, Polaroid Corp ., Cambridge, MA) .
Individual cells from double-labeled experiments (fluorescein-a2M and Dil-labeled lipoproteins) were analyzed for overlap of fluorescent vesicles as follows : autofluorescence and out-of-focus background fluorescence in the digitized images were removed by applying a 32 x 32 pixel (5.5 x 5.5 /m) median filter to a digitized image, and subtracting the result from the original image. Individual endocytic vesicles were detected as contiguous groups of pixels with an intensity greater than a specified threshold . Pixels not removed by background subtraction were eliminated by deleting from a vesicle any pixel with an intensity <50% of the maximum intensity of the vesicle . This procedure separates close but distinct vesicles while retaining an accurate relative measure of intensity for each vesicle (6) . Next, images were aligned to correct for the small relative offset of the images resulting from the use of different filter sets for fluorescein and Dil fluorescence. In addition, a few cells failed to endocytose significant amounts of a2M . To avoid underestimating the amount of overlapping vesicles, a2M-negative cells were individually removed from both images in the double-label pair. Finally, these pairs of processed images of endosomes were used to determine whether individual endosomes contained both labeled ligands . If < 25 % of the pixels in a RVLDL-containing endosome overlapped with an a2M-containing endosome, the endosome was considered to lack a2M . The number and total intensity of nonoverlapping endosomes was determined, and expressed as a fraction of the total number or total intensity of endosomes in an image. Several images were analyzed for each experimental condition, with each image containing 3-5 cells .
SDS-PAGE
,QVLDL fractions were dialyzed against 0 .01% EDTA, lyophilized, delipidated with chloroform/methanol, and resolubilized in SDS sample loading buffer according to the method of King and Laemmli (19) . The samples (10 kg) were electrophoresed under reducing conditions on a 5-20% gradient SDS-polyacrylamide gel . The protein bands were stained with Coomassie blue, and the wet gels were scanned on a densitometer (model GS300, Hoefer Sci . Instrs., San Francisco, CA) . The data were integrated using gel scanner software (DataLab, St. Jude's Children's Hospital, Memphis, TN) on an Apple computer. The molecular mass markers used were lysozyme (14. were incubated with DiI-LDL (20 Ag/ml) plus fluorescein-aZM (100 jAg/ml) as above; the LDL pattern is shown in D, the aZM pattern is shown in E, and the phase image is shown in F.
Bar, 10 j,m.
OtherAssays 125 1-lipoprotein degradation and binding assays and whole cell ACAT assays were performed as previously described (37 
Results
Characterization and Endocytic Patterns ofCanine (3-VLDL Subfractions
Research from our laboratories has recently demonstrated that endocytosis ofrabbit /3VLDL by mouse peritoneal macrophages resulted in a pattern of endocytosis distinct from that of LDL ; the LDL was rapidly targeted to perinuclear lysosomes whereas much of the rabbit aVLDL was targeted to more widely distributed vesicles (37) . During some initial experiments designed to elucidate the properties of /3VLDL responsible for its distinctpattern of endocytic targeting, occasional rabbit ,QVLDL preparations were noted to give a more "mixed" pattern of endocytosis (i .e ., central plus widely distributed) than the mostly widely distributed pattern of other rabbit (3VLDL preparations . In further experiments, (3-VLDL obtained from cholesterol-fed dogs was found to consistently give a "mixed" pattern of endocytosis.
The double-label fluorescence micrographs shown in Fig . 1 compare the endocytic patterns of DiI-canine /3VLDL and DiI-LDL with that of fluorescein-012M, which, like LDL, is rapidly targeted to central lysosomes (see reference 37 and below) and thus can serve as a reference for comparison of endocytic patterns . The comparison of the DiI-canine a VLDL pattern ( Fig . 1 A) with the fluorescein-a2M pattern ( Fig . 1 B) showed that the canine (3VLDL pattern contained many central vesicles that overlapped with fluorescein-a2M as well as some nonoverlapping, widely distributed vesicles ; the phase photomicrograph of these cells is shown in Fig .  1 C. This comparison was in contrast to the comparison of Df-LDL ( Fig . 1 D) with fluorescein-a2M ( Fig . 1 E) , where the overlap in fluorescence was almost complete. Thus, canine (3VLDL was targeted to both central lysosomes and more widely distributed vesicles in mouse peritoneal macrophages . This pattern of endocytosis was different from those of LDL and a2M, which were almost completely targeted to central lysosomes, and from most preparations of rabbit (3VLDL, which were targeted much more to the widely distributed vesicles (37).
The "mixed" endocytic pattern of canine aVLDL was further explored with the idea that such studies might reveal properties of aVLDL which were important in its targeting to the widely distributed vesicles. Along these lines, experiments were designed to determine whether this heterogeneous pattern was related to another area in which canine aVLDL heterogeneity had been demonstrated: particle size and origin . Cholesterol-fed dogs give rise to large, intestinally derived (3VLDL particles as well as smaller, hepatically derived particles (9) . Therefore, DiI-labeled canine OVLDL was size fractionated using gel filtration chromatography (BioGel A-150m), and the fractions were examined for their endocytic patterns and ACAT stimulatory potential . Table I . Compared to the smaller SVLDL, the larger particles have a higher triglyceride content and lower protein, cholesterol, and phospholipid contents . In addition, Coomassie-stained 5-20% gradient SDS-PAGE of canine holo-/3 VLDL (which consists mostly of smaller (3VLDL, see above) and pooled fractions D-F revealed that these fractions were enriched in Apo B-100 (data not shown), consistent with the hepatic origin ofsmall SVLDL.
In contrast, the Apo B bands offractions A-C were enriched in Apo B-48, consistent with their intestinal origin. Lastly, since each fVLDL particle contains one copy ofApo B, one
can obtain an estimate of the relative Apo E content per ,QVLDL particle by calculating for each fraction the densitometric ratio of the Apo E band to the Apo B bands (correcting for the smaller size of Apo B-48 vs. Apo B-100) .
The results ofthis analysis are shown in Table I ; note that the analysis estimates the relative Apo E/Apo B ratios among the fractions, not the absolute molar ratio of each fraction . The data corroborate previous data (9) and show that the fractions of large QVLDL (A-C) have a -4-9-fold higher Apo E/Apo B ratio (i.e., Apo E/particle ratio) than the fractions of smaller OVLDL (D-F).
The endocytic patterns of the six canine DiI-,8VLDL fractions in mouse peritoneal macrophages are shown in Fig.  3 . In this experiment, each of the fractions was incubated with the macrophages for 5 min and then chased in the absence oflipoproteins for 5 min . The cells were then fixed and viewed by fluorescence microscopy (Fig. 3, A-F ) and phasecontrast microscopy (Fig. 3, A'-F') . The micrographs show a marked difference in pattern between the biggest fractions (A and B) and the smallest fractions (E and F): fractions A and B gave a preponderance of widely distributed vesicles (reminiscent of the rabbit OVLDL patterns shown in reference 37) whereas fractions E and F were mostly central, like the patterns for LDL or a2M (refer to Fig . 1 ) . Fractions C and D appeared to give patterns that were "mixed" or intermediate between those of the largest and smallest fractions . Thus, the endocytic patterns of large and small canine (3VLDL subfractions differed, and this heterogeneity was most likely the basis for the "mixed" pattern of endocytosis seen with canine holo-(iVLDL.
To quantify these fluorescence microscopy data using a larger number of cells, a double-label study was conducted in which the endocytic patterns of each of the different ,BVLDL subfractions were directly compared (that is, in the same cell) to the endocytic pattern of fluorescein-a2M, Tabas Holo-O-VLDL from cholesterol-fed dogs was isolated, fractionated on BioGel A-150m (see Fig . 2 ), and analyzed for protein and lipid composition (by weight) as described in Materials and Methods . Fx, fraction; Prot, protein; Choi, cholesterol ; TG, triglyceride ; PL, phospholipid .
For the densitometric Apo E/Apo B ratios, canine holo-o-VLDL and fractions A-C, and pooled fractions D-F were subjected to 5-20% SDS-PAGE under reducing conditions and then stained with Coomassie blue and analyzed by densitometry as decribed in detail in Materials and Methods . The densitometric Apo E/Apo B ratio for each of the fractions (as an estimate of the relative Apo E//3-VLDL particle ratios) was calculated as follows : densitometry value of Apo E -(densitometry value of Apo B-100 + 2 x densitometry value of Apo B-08) . (The densitometry value of Apo B-48, which is approximately one-half the size of Apo B-100, was multiplied by two to correct for the likelihood that, per molecule, its staining intensity would be about half that of Apo B-100. . When this analysis was applied to another experiment using a different preparation of DiI-labeled canine (3VLDL subfractions, similar results were obtained. Thus, the quantitative analysis of fluorescent patterns in multiple images corroborated the impressions gained from viewing the fluorescence micrographs in Fig. 3 and demonstrated that canine O-VLDL large subfractions gave a more widely distributed pattern of endocytosis in macrophages than /3VLDL small subfractions.
ACAT-stimulatory Pbtential ofCanine O-VLDL Subfractions
Based upon our previous study comparing the endocytic pattems and ACATstimulatory potentials of rabbit fVLDL and human LDL, a causal relationship between the widely distributed endocytic pattern of rabbit OVLDL and its high ACATstimulatory potential was hypothesized (37) the different endocytic patterns of canine aVLDL subfractions (see above), experiments were conducted to determine if there was a correlation between the endocytic targeting and ACATstimulatory potential of these subfractions. Therefore, 1151-labeled canine SVLDL subfractions and canine holoaVLDL were incubated with macrophages for 6 h, the last 2 h of which included 1°C-oleate, and cellular cholesteryl 1'C-oleate was measured to determine ACAT activity (Fig .  5 A) . The data show that the large subfractions of ,QVLDL (i.e., fractions A and B) stimulated ACAT much greater than the smaller subfractions and holo-aVLDL. However, it was necessary to determine how much of this difference could be explained simply by increased cellular cholesterol delivery by the large O3VLDLs. Therefore, cellular "5 I_S VLDL degradation was assayed (Fig. 5 B, . The data show that although the larger subfractions did, in fact, deliver more cholesterol to the cells, this increased delivery could not fully account for the increased ACAT differences . This point is directly illustrated in Fig . 5 C, where the values are expressed as an "ACAT activity/cholesterol delivery ratio" to correct ACAT activity differences for differences in cellular cholesterol delivery. The data clearly show that the larger (3VLDL subfractions have a significantly greater ACATstimulatory potential than the smaller subfractions . This profile is very similar in appearance to the profile of the quantitative endocytic data forthe subfractions shown in the mechanism of uptake by macrophages of Fx A (large) (3VLDL was similar to that reported for canine holo-(3VLDL, i.e., receptor-mediated endocytosis via interaction ofOVLDL Apo E molecules with the macrophage's LDL receptor (2, 7, 15, 22) . Fluorescence microscopy experiments revealed that both a monoclonal antibody against the receptor-binding region ofApo Eand a polyclonal antibody against the ligand-binding region of the LDL receptor each blocked macrophage uptake of the large, as well as small, a-VLDL particles (data not shown) . In contrast, a monoclonal antibody against the receptor-binding region of Apo B100 did not block uptake of the large, or small, S-VLDL (data not shown) . These data indicated that large (3VLDL, like small fVLDL and holo-O VLDL (2, 7, 15, 22) , are internalized by macrophages via interaction of the Apo E molecules of the SVLDL with the macrophage LDL receptor. The next goal was to determine if the large fraction A particles were internalized by a phagocytic mechanism. In macrophages, phagocytosis is much more susceptible than endocytosis to inhibition by the cytoskeletal inhibitor, cytochalasin B (18, 20) . Therefore, the uptake and degradation of X 25 1-labeled large (3VLDL, small /3VLDL, LDL, and aggregated LDL in mouse peritoneal macrophages, in the absence or presence of cytochalasin B, was measured (Fig. 6) . The degradation of 125 1-aggregated LDL, which consists of complexes much larger in size than large /3VLDL and which is known to be internalized by macrophages via a phagocytic mechanism (18), was, as expected, inhibited by cytochalasin B (Fig. 6, A) . In contrast, large #3VLDL (Fig. 6,,&) , as well as small OVLDL (9) and LDL (0), demonstrated relative resistance to the inhibitory effects of cytochalasin B. Thus, by this functional definition of phagocytosis, large OVLDL particles are not internalized by macrophages via a phagocytic mechanism.
The Effect ofPartial Antibody-mediated Neutralization ofApo E on the Endocytic Targeting and ACAT-stimulatory Fbiential ofLarge O-VLDL A prominent, distinguishing characteristic of large ,QVLDL molecules is that they contain more copies of Apo E per particle than small ,BVLDL (see above, Table 1 , and reference 9). Thus, the possible role of multivalent Apo E in the endocytic targeting and ACATstimulatory potential of large OVLDL was explored. For this purpose, DiI-labeled large (3VLDL was titrated with an amountofanti-Apo E antibody that partially blocked cellular uptake, thereby decreasing the valency of functional Apo E molecules on the particle. This antibody-treated /3VLDL was then compared with control SVLDL (treated with irrelevant antibody) for endocytic targeting and ACATstimulatory potential . For these experiments, a preparation ofDiI-labeled rabbit OVLDL was used which was similar in size, endocytic targeting, ACATstimulatory potential, and Apo E content to canine fraction A S-VLDL. (DiI-labeled rabbit OVLDL was used because it could be more intensely labeled with DiI than fraction A canine (3VLDL, and thus the endocytic pattern ofthis lipoprotein in the presence of partially blocking amounts of anti-Apo E antibody could be better viewed .)
The endocytic targeting data is shown in Fig . 7 . A and B show a double-label study comparing the endocytic patterns of fluorescein-a2M and DiI-labeled (3VLDL, respectively, in the same field of cells. As expected, the SVLDL pattern included numerous widely distributed vesicles that were absent in the central fluorescein-01 2M pattern. Fig. 7 , C and D, shows a similar double-label study comparing the patterns of fluorescein-a2M and partial anti-Apo E-treated DiIlabeled /3VLDL, respectively. In contrast to the control aVLDL pattern (above), the antibody-treated /3VLDL pattern was noticeably more central (Fig. 7 B) , and there was much more overlap with the fluorescein-a2M pattern (Fig.  7 C) . (The patterns of the control and anti-Apo E-treated /3VLDLs are of similar brightness since high concentrations of ,QVLDL were used [50 jAg/ml], thus assuring receptor saturation even with the anti-Apo E-treated /3VLDL.) To prove that the antibody-treated SVLDL was internalized by the LDL receptor, we showed that the uptake could be blocked by preincubating cholesterol-loaded cells with anti-LDL receptor antibody. The Fc receptor was not involved in the uptake of anti-Apo E-treated S VLDL since identical results were obtained using Fab fragments generated from the 1171 antibody (using the quantitative methodology described for Fig . 4 , 55 f 4 % ofthe vesicles from control Dillabeled aVLDL images did not overlap with fluoresceina2M vesicles, whereas only 28 t 6% of the vesicles from anti-Apo E Fab-treated DiT-labeled /3VLDL images were nonoverlapping [means f SD, n = 7 images]). Thus, treatment of large SVLDL with an amount of anti-Apo E antibody that probably resulted in a decrease in the valency of functional Apo E molecules ofthe particles led to more central targeting of the (3VLDL.
Based upon the ACAT hypothesis described above, the possibility that this change to a more central pattern was associated with a decrease in the ACATstimulatory potential of the antibody-treated QVLDL was investigated (Fig. 8) . Thus, macrophages were incubated with 5 ;&g/ml control or 10 wg/ml partial anti-Apo E-treated 'H-CE-labeled large /3VLDL for 5 h in the presence of 14C-oleate. Lipid extracts of the cells were assayed for both unesterified and esterified shown in A and B, macrophages were incubated (6-min pulse/4-min chase) with 50 Ag/ml Dil-labeled large rabbit aVLDL (preincubated with 50,ug/ml of an control antibody) plus 100 pg/ml fluorescein-01 2 M . The cells were then fixed and viewed for fluorescein (A) and DiI (B) . In the experiment shown in C and D, a similar protocol was used except 50 ug/ml Dil-labeled /3 VLDL was preincubated with 50 ug/ml antiApo E antibody before incubation (plus fluorescein-012M) with macrophages . The fluorescein (UN) pattern is shown in C and the Dil (,QVLDL) pattern is shown in D. Bar, 10,um . data show that partial antiApo E treatment of /iVLDL led to a twofold decrease in ACATderived CE under conditions in which the lipoprotein-cholesterol delivered to the cells was similar. Thus, anti-Apo E treatment of large ,EVLDL changed both the endocytic pattern and the ACATstimulatory potential of the lipoprotein, furthering the correlation between a widely distributed endocytic pattern and a high ACATstimulatory potential .
ThepH-dependent Release ofLarge and Small Canine S-VLDLfrom Macrophage Surface LDL Receptors
The endocytic pathway for LDL, like that for many other endoThe Journal of Cell Biology, Volume 115, 1991 cytosed ligands, involves an acid-dependent dissociation ofligand from receptor in the sorting endosome ; the ligand is then targeted to lysosomes, and the receptor is targeted to the plasma membrane via a recycling pathway (13) . Thus, part of the basis for the different endocytic targeting of small /3VLDL (to perinuclear lysosomes) and large /3VLDL (to more widely distributed vesicles) might be a difference in acid-mediated ligand-receptor dissociation for the two (3VLDLs in the sorting endosome . For instance, if the large (3VLDL were more resistant to acid-mediated ligand-receptor dissociation, less of the /3VLDL would be released from its receptor and delivered to perinuclear lysosomes . As an The culture medium was then removed, and the cells were washed and incubated with DME/0 .2% BSA in the absence of lipoproteins for 30 min so that any surface bound 3H-CE-/3VLDL would be internalized by the cells (37) . Lipid extracts of the cells were then analyzed by TLC for unesterified and esterified (large) canine a VLDL was incubated with macrophages at 4°C for 3 h at pH 7.4. The cells were then washed, and individual monolayers were incubated at 4°C for 20 min in buffered solutions ranging in pH from 7.0 to 5.0. Cell-associated and media '251 were measured to determine the percent release of ligand from the cell surface receptors (Fig. 9 A) . The data clearly show a difference in the release of large and small aVLDL's: small (3VLDL (Fx F; o) was progressively released from cell surface receptors as the pH was lowered from 7.0 to 5.0. Similar results were found with LDL (data not shown) . In contrast, large /3VLDL (Fx A; 9) showed a marked resistance to acid-mediated release from the receptors .
To further explore this idea, an experimentwas designed to determine whether partial anti-Apo E treatment of /3VLDL, which changes its endocytic targeting to a more central pattem (see above and Fig . 7) , resulted in an increase in the acid-dependent release of the aVLDL from its receptor. As shown in Fig . 9 B, '25 x-labeled large rabbit ,QVLDL was treated in the absence or presence of two concentrations of anti-Apo E Fab (weight ratios of Fab to "'I-aVLDL protein = 5 :1 and 12.5:1, respectively) . Macrophages were then incubated at 4°C with the untreated and Fab-treated 'ZSI-aVLDLs, and then the cells were postincubated (at 4°C) in pH 5.5 buffer ; the relative amounts of cell-associated and released '251-RVLDL were determined. The data show that antiApo E Fab treatment of ,QVLDL resulted, in a dosedependent manner, in a greater release of '251-(3VLDL from cell surface receptors at pH 5.5. Thus, a functional decrease in (3VLDL-Apo E valency by partial anti-Apo E treatment resulted in both a more central endocytic pattern (see Fig .  7 ) and an increase in acid-mediated release from cell surface receptors (see Fig. 9 B) . These findings support the hypothesis that multivalent Apo E on large OVLDL particles, perhaps through receptor cross-linking, results in decreased dissociation of the particles from their receptors in acidic sorting endosomes, which, in turn, may contribute to their targeting to widely distributed vesicles in mouse peritoneal macrophages. In our previous study, rabbit /3VLDL and human LDL, despite being internalized by the same receptor, were shown to have divergent endocytic pathways in mouse peritoneal macrophages (37) . A major goal resulting from that study was to determine the properties of aVLDL important in its divergent pattern of endocytosis . The current study has approached this issue by first showing that the widely distributed pattern of endocytosis characteristic of rabbit OVLDL was seen only with the large, intestinally derived subfraction of canine ,BVLDL. (Subsequently, most ofour rabbit aVLDL preparations were shown to be heavily enriched in Apo E-rich, large ,QVLDL [our unpublished data], thus explaining why these preparations of holo-aVLDL from rabbit gave a mostly widely distributed pattern.) With this finding, the specific properties of large /3VLDL, distinct from those of small ,Q VLDL, that might be responsible for the widely distributed pattern of endocytosis could be investigated . Since most of canine holo-,B VLDL is made up of small SVLDL (Fig. 2) , one possibility not ruled out by previous studies with holo-/3 VLDL from dogs was that large OVLDL particles were internalized by a different receptor or different mechanism from small (3VLDL. In particular, given the very large size of the large (3VLDL particles, there was a possibility that these particles were phagocytosed by the macrophages . However, the cytochalasin B experiment (Fig.  6) showed that the uptake was relatively resistant to disruption ofthe actin cytoskeleton, thus indicating that uptake by a classical phagocytosis mechanism was unlikely (18, 20) . Furthermore, the uptake of the large particles, like that of canine holo-,QVLDL (2, 7, 15, 22) , was dependent upon Apo E of the SVLDL interacting with the macrophage's LDL receptor (see text). In particular, the fact that an LDL receptor antibody blocked particle uptake and thiol estercleaved a2-macroglobulin did not block uptake (data not shown; see reference 16) indicated that the LDL receptorrelated protein/a2-macroglobulin receptor (23) was not involved in the uptake of large aVLDL. From these combined data, we concluded that the divergence in endocytosis be- Figure 9 . The effect of SVLDL particle size and anti-Apo E Fab treatment on the pH-dependent release of /3VLDL from macrophage cell surface receptors . In A, 1231-labeled fraction A (e) or fraction F canine ,BVLDL (0) (4 ug/ml) was incubated with macrophages at 4°C for 3 h in DME/25 mM Hepes (pH 7.4)/10% lipoprotein-deficient serum. The cells were then washed with PBS/0.2% BSA and incubated with 50 mM NaCI/5 % lipoproteindeficient serum containing 50 mM Tris-succinate (pH 5.0 or 5.5) or 50 mM Tris-maleate (pH 6.0, 6.5, or 7.0) for 20 min at 4°C . Cellassociated and media 123 1-cpm were measured, and the data are expressed as 123 1-cpm in the medium as a percent of total (i.e., medium + cell-associated) 1231-cpm . In B, 10 pg/ml 123 1-labeled large rabbit OVLDL was incubated for 1 h at 37°C in the absence or presence of50 or 125 pg/ml anti-Apo-E Fab (indicated, respectively, as Ratio Fab :0 = 0:1, 5 :1, or 12.5 :1). The labeled SVLDLs were subject to the same acid-release experiment described for A except that only pH 7.0 and 5.5 buffers were used. The pH 5.5 percent release data is shown. The total 1231-/3VLDL originally bound to the cells before addition of buffer (i.e., buffer-released plus cell-associated) was 115.8 f 5.4, 111 .1 t 7.3, and 114.6 t 3.2 ng/mg cell protein for the three Fab :,Q ratios, respectively. The percent releases at pH 7.0 for Fab :0 ratios of 0:1 and 12.5 :1 were, respectively, 33.2 f 0.1% and 31.6 f 0.1% . When a nonimmune Fab was used at a ratio of 12.5 :1, the values were the same as those obtained in the absence of Fab (i.e., ratio 0:1) . Values are means t SEM (n = 3).
tween large vs. small R VLDL was not due to phagocytosis of the large particles or binding to different receptors. Another possibility to explain the endocytic divergence was particle size itself. The diameter of large OVLDL particles (see Fig . 2, inset) is similar to or larger than the diameters of coated pits and endocytic vesicles, and it is conceivable that a vesicle loaded to capacity with one large particle may undergo alternative routing due to changes in the interaction or fusion ofthe vesicle with other cellular organelles. However, the finding that partial anti-Apo E treatment of large (3VLDL resulted in the particles' being targeted more centrally (see Fig. 7) demonstrates that large particle size alone is not sufficient for targeting to widely distributed vesicles.
A third possibility for the endocytic divergence is related to the greater number of Apo E molecules per large (3VLDL (vs . small aVLDL) that might result in differences in aVLDL-receptor interactions. An important role for multiple Apo E's is suggested by the data in Fig . 7 , which shows that functional depletion ofApo E molecules on large /3VLDL by titration with anti-Apo E antibody leads to an almost total elimination oftargeting to widely distributed vesicles. An attractive hypothesis relating Apo E and endocytic targeting is that the multivalent Apo E on large (3VLDL might lead to a greater degree of receptor cross-linking than those on small (3VLDL, which, in turn, may be responsible for the greater resistance ofthe large aVLDL to acid-mediated release from receptors (see Fig. 9 ). If there is diminished acid-induced ligand-receptor dissociation in the acidic sorting endosome, the normal rapid delivery of dissociated ligand to perinuclear lysosomes would not occur as completely as it does with small aVLDL, LDL, or U2M . Instead, a substantial portion of the ,QVLDL would possibly end up in recycling endosomes (like transferrin [5, 21] ) or some other vesicles distal to sorting endosomes . Attempts to colocalize large ,QVLDL and transferrin have been unsuccessful because of the low amount of uptake of transferrin in mouse peritoneal macrophages . In addition, we have been unable to detect significant recycling of internalized /3VLDL (our unpublished data) . Thus, the actual identity and fate of the OVLDL-containing vesicles must await further experimentation .
Previous work has indicated that receptor cross-linking can block ligand-receptor recycling . Hopkins and Trowbridge (14) showed that multivalent transferrin on gold particles was targeted first to multivesicular bodies and then to lysosomes in human carcinoma A431 cells instead of being recycled like univalent transferrin . Similarly, Weissman et al. (38) found that exposure ofhuman erythroleukemia K562 cells to a divalent antitransferrin receptor antibody blocked receptor recycling, perhaps through receptor cross-linking . Melhnan and Plutner (26) demonstrated that Fc receptors on J774 cells and thioglycollate-elicited mouse peritoneal macrophages were recycled when exposed to monovalent ligands but were delivered to lysosomes when exposed to polyvalent IgG complexes . Other receptors whose recycling was blocked by polyvalent antibodies include the LDL receptor on human fibroblasts (1), the insulin receptor on IM-9 lymphocytes (32) , and the cation-independent (215-kD) phosphomannosyl receptor on human fibroblasts (29) . In several of the examples above, the multivalent-bound receptors were targeted to lysosomes . Interestingly, however, the intracellular distribution ofphosphomannosyl receptors changed from their normal juxtanuclear site to a more peripheral distribution upon addition ofpolyvalent antibody (29) . The hypothesis put forth here is that LDL receptor cross-linking on mouse peritoneal macrophages (i.e., by "multivalent" large a VLDL) changes endocytic targeting on the ligand from a lysosomal distribution to, at least initially, a more widely distributed pattern. The explanation of why, in our case, putative receptor cross-linking leads to a more peripheral endocytic, and less lysosomal, pattern awaits further investigation into the nature of the (3VLDL-containing vesicles, the eventual fate of RVLDL in our cells, and the targeting of lipoproteins such as ,QVLDL in different cell types . Nonetheless, the possibility that LDL receptor cross-linking by large OVLDL results in its endocytic divergence from small ,QVLDL and LDL may represent an important physiological example ofthe effect ofreceptor cross-linking on endocytic targeting .
The original impetus for our previous study on the divergent endocytic pathways of,8VLDL and LDL in mouse peritoneal macrophages was ahypothesis which attempted to explain the greater ability of QVLDL to stimulate ACAT in these cells (37) . According to this hypothesis, the targeting of /3VLDL to a set of vesicles distinct from those of LDL would lead to a greater stimulation of ACAT by the /3VLDL. The actual mechanism might involve a physical association ofthe ,QVLDL-containing vesicles with ACAT (or proximity to the enzyme) . Alternatively, the OVLDL-containing vesicles may possess some property, such as increased ability to transfer cholesterol, that would lead to increased ACAT stimulation. Although the current study does not directly address these possible mechanisms, the data continue to support the overall hypothesis linking endocytic targeting with ACAT stimulation. For instance, large /3VLDL are targeted in a more widely distributed pattern than small OVLDL (see Figs. 3 and 4 ) and also have a higher ACAT stimulatory potential than the smaller particles (see Fig. 5 ). Similarly, the partial anti-Apo E treatment of aVLDL changed its targeting to a more central pattern (see Fig . 7 ) and also decreased its ability to stimulate ACAT (see Fig . 8 ) . Thus, the study strengthens the correlation between the targeting of O3VLDL to widely distributed vesicles and high ACAT stimulation and therefore further supports the causal nature of this relationship .
The widely distributed endocytic pattern and high ACAT stimulatory potential of large RVLDL may have particular relevance to our understanding of atherogenesis . Large O3 VLDL, which is intestinally derived, has structural and metabolic properties similar to those of postprandial chylomicron remnants (9) , which may be a relatively common atherogenic particle in man (39) . Thus, by studying in detail the pathways and metabolism of these particles in macrophages, the cell type that leads to atheroma foam cells (8, 10, 34) , further insight into their association with atherogenesis may be gained . Although our current hypothesis has focused on the relationship between the endocytic pathway of these particles and ACAT stimulation, it is possible that other or additional consequences of the pathway (e.g., specific proteolytic processing ofthe proteins or catabolism ofthe lipids of large /3VLDL) may be revealed and shown to be physiologically important .
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